Cyndeo Wealth Partners’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$303K Sell
576
-5
-0.9% -$2.8K 0.01% 433
2026
Q1
$326K Sell
581
-47
-7% -$30.1K 0.02% 392
2025
Q4
$425K Buy
628
+56
+10% +$38.1K 0.02% 343
2025
Q3
$365K Buy
572
+9
+2% +$5.46K 0.02% 357
2025
Q2
$302K Buy
563
+7
+1% +$3.35K 0.02% 382
2025
Q1
$233K Buy
556
+3
+0.5% +$1.3K 0.02% 416
2024
Q4
$229K Sell
553
-11
-2% -$4.83K 0.02% 411
2024
Q3
$285K Buy
564
+7
+1% +$3.4K 0.02% 375
2024
Q2
$271K Sell
557
-9
-2% -$4.52K 0.02% 344
2024
Q1
$306K Buy
566
+146
+35% +$79.8K 0.03% 323
2023
Q4
$233K Sell
420
-106
-20% -$49.8K 0.02% 335
2023
Q3
$230K Buy
526
+2
+0.4% +$997 0.02% 306
2023
Q2
$263K Buy
524
+28
+6% +$13.4K 0.03% 283
2023
Q1
$248K Buy
+496
New +$237K 0.03% 286

Other funds holding IDXX

Cyndeo Wealth Partners's IDXX Position: Q2 2026 in Review

Cyndeo Wealth Partners reduced its Idexx Laboratories (IDXX) stake by 0.86% in Q2 2026, selling an estimated $2.8K and leaving 576 shares worth $303K. The position accounts for 0.01% of the portfolio, ranked #433.

Cyndeo Wealth Partners first reported a position in IDXX in Q1 2023 and has held it in 14 quarters since. The position peaked at $425K in Q4 2025. 235 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Cyndeo Wealth Partners held 576 shares of Idexx Laboratories worth $303K as of Q2 2026.
  • Cyndeo Wealth Partners sold 5 Idexx Laboratories shares in Q2 2026, an estimated $2.8K.
  • Idexx Laboratories made up 0.01% of Cyndeo Wealth Partners's portfolio in Q2 2026, its #433 holding.
  • Cyndeo Wealth Partners first reported a position in Idexx Laboratories in Q1 2023 and has held it in 14 quarters since.
  • Cyndeo Wealth Partners's Idexx Laboratories position peaked at $425K in Q4 2025.
  • 235 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Cyndeo Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.